Quality of life 4 years after complex heart surgery in infancy

Gonzalo Garcia Guerra1, Charlene M T Robertson, Gwen Y Alton

  • 1Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada. Gonzalo.Guerra@albertahealthservices.ca

Insights

Children undergoing early congenital heart disease surgery had lower quality of life at age 4. Factors like surgery timing and socioeconomic status impacted these outcomes.

Area of Science:

  • Pediatric Cardiology
  • Quality of Life Research
  • Congenital Heart Disease Outcomes

Background:

  • Congenital heart disease (CHD) necessitates early surgical intervention.
  • Long-term health-related quality of life (HRQoL) post-infancy cardiac surgery requires further investigation.

Purpose of the Study:

  • To assess HRQoL at 4 years of age in infants treated for CHD.
  • To identify perioperative factors associated with HRQoL outcomes.

Main Methods:

  • Prospective cohort study of infants undergoing cardiac surgery before 6 weeks of age.
  • HRQoL assessed at age 4 using the Pediatric Quality of Life Inventory (PedsQL) 4.0.
  • Comparison with normative data and exploration of perioperative variable associations.

Main Results:

  • 130 survivors of complex heart surgery were evaluated.
  • Children with biventricular repair showed lower overall and psychosocial PedsQL scores compared to norms.
  • Single ventricle repair patients had lower physical health scores; older surgery age and low cardiac output syndrome correlated with worse HRQoL.

Conclusions:

  • Infants undergoing early cardiac surgery for CHD experience diminished HRQoL at age 4.
  • Age at surgery, postoperative low cardiac output syndrome, and socioeconomic status are significant predictors of long-term HRQoL.
Abstract

Related Concept Videos

Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...